These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 36509982)
1. The insula modulates the effects of aerobic training on cardiovascular function and ambulation in multiple sclerosis. Albergoni M; Storelli L; Preziosa P; Rocca MA; Filippi M J Neurol; 2023 Mar; 270(3):1672-1681. PubMed ID: 36509982 [TBL] [Abstract][Full Text] [Related]
2. Gray matter trophism, cognitive impairment, and depression in patients with multiple sclerosis. Pravatà E; Rocca MA; Valsasina P; Riccitelli GC; Gobbi C; Comi G; Falini A; Filippi M Mult Scler; 2017 Dec; 23(14):1864-1874. PubMed ID: 28169581 [TBL] [Abstract][Full Text] [Related]
3. Detection and quantification of regional cortical gray matter damage in multiple sclerosis utilizing gradient echo MRI. Wen J; Yablonskiy DA; Luo J; Lancia S; Hildebolt C; Cross AH Neuroimage Clin; 2015; 9():164-75. PubMed ID: 27330979 [TBL] [Abstract][Full Text] [Related]
4. Functional and structural plasticity following action observation training in multiple sclerosis. Rocca MA; Meani A; Fumagalli S; Pagani E; Gatti R; Martinelli-Boneschi F; Esposito F; Preziosa P; Cordani C; Comi G; Filippi M Mult Scler; 2019 Oct; 25(11):1472-1487. PubMed ID: 30084706 [TBL] [Abstract][Full Text] [Related]
5. Characterization of gray-matter multiple sclerosis lesions using double inversion recovery, diffusion, contrast-enhanced, and volumetric MRI. Parra Corral MA; Govindarajan ST; Stefancin P; Bangiyev L; Coyle PK; Duong TQ Mult Scler Relat Disord; 2019 Jun; 31():74-81. PubMed ID: 30951968 [TBL] [Abstract][Full Text] [Related]
6. QTc interval in patients with multiple sclerosis: an inference from the insula of Reil? Turri G; Calabrese M; Pancheri E; Monaco S; Gajofatto A; Marafioti V Eur J Neurol; 2017 Mar; 24(3):491-496. PubMed ID: 28111831 [TBL] [Abstract][Full Text] [Related]
7. A longitudinal uncontrolled study of cerebral gray matter volume in patients receiving natalizumab for multiple sclerosis. Khalid F; Tauhid S; Chua AS; Healy BC; Stankiewicz JM; Weiner HL; Bakshi R Int J Neurosci; 2017 May; 127(5):396-403. PubMed ID: 27143245 [TBL] [Abstract][Full Text] [Related]
8. Quantitative MRI analysis of cerebral lesions and atrophy in post-partum patients with multiple sclerosis. Khalid F; Healy BC; Dupuy SL; Chu R; Chitnis T; Bakshi R; Houtchens M J Neurol Sci; 2018 Sep; 392():94-99. PubMed ID: 30031994 [TBL] [Abstract][Full Text] [Related]
9. Gray Matter Atrophy in the Cortico-Striatal-Thalamic Network and Sensorimotor Network in Relapsing-Remitting and Primary Progressive Multiple Sclerosis. Cao Y; Diao W; Tian F; Zhang F; He L; Long X; Zhou F; Jia Z Neuropsychol Rev; 2021 Dec; 31(4):703-720. PubMed ID: 33582965 [TBL] [Abstract][Full Text] [Related]
10. Exploration of the relationships between regional grey matter atrophy and cognition in multiple sclerosis. Nocentini U; Bozzali M; Spanò B; Cercignani M; Serra L; Basile B; Mannu R; Caltagirone C; De Luca J Brain Imaging Behav; 2014 Sep; 8(3):378-86. PubMed ID: 22584774 [TBL] [Abstract][Full Text] [Related]
11. Insular multiple sclerosis lesions are associated with erectile dysfunction. Winder K; Linker RA; Seifert F; Deutsch M; Engelhorn T; Dörfler A; Lee DH; Hösl KM; Hilz MJ J Neurol; 2018 Apr; 265(4):783-792. PubMed ID: 29392463 [TBL] [Abstract][Full Text] [Related]
13. Cortical diffusion kurtosis imaging and thalamic volume are associated with cognitive and walking performance in relapsing-remitting multiple sclerosis. Nygaard MKE; Langeskov-Christensen M; Dalgas U; Eskildsen SF J Neurol; 2021 Oct; 268(10):3861-3870. PubMed ID: 33829319 [TBL] [Abstract][Full Text] [Related]
14. Corpus callosum atrophy correlates with gray matter atrophy in patients with multiple sclerosis. Klawiter EC; Ceccarelli A; Arora A; Jackson J; Bakshi S; Kim G; Miller J; Tauhid S; von Gizycki C; Bakshi R; Neema M J Neuroimaging; 2015; 25(1):62-7. PubMed ID: 24816394 [TBL] [Abstract][Full Text] [Related]
15. A two-year study using cerebral gray matter volume to assess the response to fingolimod therapy in multiple sclerosis. Yousuf F; Dupuy SL; Tauhid S; Chu R; Kim G; Tummala S; Khalid F; Weiner HL; Chitnis T; Healy BC; Bakshi R J Neurol Sci; 2017 Dec; 383():221-229. PubMed ID: 29146095 [TBL] [Abstract][Full Text] [Related]
16. Cognitive reserve, cognition, and regional brain damage in MS: A 2 -year longitudinal study. Rocca MA; Riccitelli GC; Meani A; Pagani E; Del Sette P; Martinelli V; Comi G; Falini A; Filippi M Mult Scler; 2019 Mar; 25(3):372-381. PubMed ID: 29303036 [TBL] [Abstract][Full Text] [Related]
17. Brain activity, regional gray matter loss, and decision-making in multiple sclerosis. Weygandt M; Wakonig K; Behrens J; Meyer-Arndt L; Söder E; Brandt AU; Bellmann-Strobl J; Ruprecht K; Gold SM; Haynes JD; Paul F Mult Scler; 2018 Aug; 24(9):1163-1173. PubMed ID: 28657480 [TBL] [Abstract][Full Text] [Related]
18. Association of Deep Gray Matter Damage With Cortical and Spinal Cord Degeneration in Primary Progressive Multiple Sclerosis. Ruggieri S; Petracca M; Miller A; Krieger S; Ghassemi R; Bencosme Y; Riley C; Howard J; Lublin F; Inglese M JAMA Neurol; 2015 Dec; 72(12):1466-74. PubMed ID: 26457955 [TBL] [Abstract][Full Text] [Related]
19. Single scan quantitative gradient recalled echo MRI for evaluation of tissue damage in lesions and normal appearing gray and white matter in multiple sclerosis. Xiang B; Wen J; Cross AH; Yablonskiy DA J Magn Reson Imaging; 2019 Feb; 49(2):487-498. PubMed ID: 30155934 [TBL] [Abstract][Full Text] [Related]
20. Subcortical deep gray matter pathology in patients with multiple sclerosis is associated with white matter lesion burden and atrophy but not with cortical atrophy: a diffusion tensor MRI study. Cappellani R; Bergsland N; Weinstock-Guttman B; Kennedy C; Carl E; Ramasamy DP; Hagemeier J; Dwyer MG; Patti F; Zivadinov R AJNR Am J Neuroradiol; 2014 May; 35(5):912-9. PubMed ID: 24335548 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]